全文获取类型
收费全文 | 28261篇 |
免费 | 2255篇 |
国内免费 | 66篇 |
专业分类
耳鼻咽喉 | 233篇 |
儿科学 | 1027篇 |
妇产科学 | 865篇 |
基础医学 | 3510篇 |
口腔科学 | 430篇 |
临床医学 | 5148篇 |
内科学 | 4910篇 |
皮肤病学 | 387篇 |
神经病学 | 2666篇 |
特种医学 | 522篇 |
外科学 | 2274篇 |
综合类 | 388篇 |
一般理论 | 64篇 |
预防医学 | 3927篇 |
眼科学 | 343篇 |
药学 | 1605篇 |
中国医学 | 26篇 |
肿瘤学 | 2257篇 |
出版年
2023年 | 161篇 |
2022年 | 220篇 |
2021年 | 489篇 |
2020年 | 415篇 |
2019年 | 714篇 |
2018年 | 738篇 |
2017年 | 553篇 |
2016年 | 660篇 |
2015年 | 726篇 |
2014年 | 915篇 |
2013年 | 1446篇 |
2012年 | 1983篇 |
2011年 | 2005篇 |
2010年 | 1108篇 |
2009年 | 1007篇 |
2008年 | 1885篇 |
2007年 | 2020篇 |
2006年 | 2014篇 |
2005年 | 1911篇 |
2004年 | 1794篇 |
2003年 | 1724篇 |
2002年 | 1625篇 |
2001年 | 241篇 |
2000年 | 200篇 |
1999年 | 232篇 |
1998年 | 397篇 |
1997年 | 279篇 |
1996年 | 275篇 |
1995年 | 257篇 |
1994年 | 226篇 |
1993年 | 222篇 |
1992年 | 136篇 |
1991年 | 112篇 |
1990年 | 110篇 |
1989年 | 117篇 |
1988年 | 103篇 |
1987年 | 81篇 |
1986年 | 99篇 |
1985年 | 121篇 |
1984年 | 103篇 |
1983年 | 110篇 |
1982年 | 137篇 |
1981年 | 134篇 |
1980年 | 137篇 |
1979年 | 51篇 |
1978年 | 57篇 |
1977年 | 56篇 |
1976年 | 60篇 |
1975年 | 50篇 |
1974年 | 45篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
992.
993.
Lauren N. DeCaporale-Ryan Ann Cornell Robert M. McCann Kevin McCormick Jenny Speice 《Gerontology & geriatrics education》2014,35(4):369-379
There has been increased attention on the needs of the burgeoning older adult population, with focus on the limited education and training experiences available in geriatric care. Older adults transitioning between levels of care often require increased attention, and the American Geriatrics Society (AGS) Task Force on the Future of Geriatric Medicine has encouraged greater training opportunities be provided to better understand the needs of this population. The Hospital to Home Program is one model of geriatric training emphasizing many of the AGS recommendations. Through qualitative analyses of 51 internal medicine residents’ reflections, the authors report how this educational program is meeting the above need and share how Hospital to Home is enhancing residents’ skills in creating a safe discharge for geriatric patients and their families. 相似文献
994.
Silent cerebral infarction,income, and grade retention among students with sickle cell anemia 下载免费PDF全文
Allison A. King Mark J. Rodeghier Julie Ann Panepinto John J. Strouse James F. Casella Charles T. Quinn Michael M. Dowling Sharada A. Sarnaik Alexis A. Thompson Gerald M. Woods Caterina P. Minniti Rupa C. Redding‐Lallinger Melanie Kirby‐Allen Fenella J. Kirkham Robert McKinstry Michael J. Noetzel Desiree A. White Janet K. Kwiatkowski Thomas H. Howard Karen A. Kalinyak Baba Inusa Melissa M. Rhodes Mark E. Heiny Ben Fuh Jason M. Fixler Mae O. Gordon Michael R. DeBaun 《American journal of hematology》2014,89(10):E188-E192
Children with sickle cell anemia have a higher‐than‐expected prevalence of poor educational attainment. We test two key hypotheses about educational attainment among students with sickle cell anemia, as measured by grade retention and use of special education services: (1) lower household per capita income is associated with lower educational attainment; (2) the presence of a silent cerebral infarct is associated with lower educational attainment. We conducted a multicenter, cross‐sectional study of cases from 22 U.S. sites included in the Silent Infarct Transfusion Trial. During screening, parents completed a questionnaire that included sociodemographic information and details of their child's academic status. Of 835 students, 670 were evaluable; 536 had data on all covariates and were used for analysis. The students' mean age was 9.4 years (range: 5–15) with 52.2% male; 17.5% of students were retained one grade level and 18.3% received special education services. A multiple variable logistic regression model identified that lower household per capita income (odds ratio [OR] of quartile 1 = 6.36, OR of quartile 2 = 4.7, OR of quartile 3 = 3.87; P = 0.001 for linear trend), age (OR = 1.3; P < 0.001), and male gender (OR, 2.2; P = 0.001) were associated with grade retention; silent cerebral infarct (P = 0.31) and painful episodes (P = 0.60) were not. Among students with sickle cell anemia, household per capita income is associated with grade retention, whereas the presence of a silent cerebral infarct is not. Future educational interventions will need to address both the medical and socioeconomic issues that affect students with sickle cell anemia. Am. J. Hematol. 89:E188–E192, 2014. © 2014 Wiley Periodicals, Inc. 相似文献
995.
Brian Kornblit David G. Maloney Barry E. Storer Michael B. Maris Lars Vindel?v Parameswaran Hari Amelia A. Langston Michael A. Pulsipher Wolfgang A. Bethge Thomas R. Chauncey Thoralf Lange Finn B. Petersen Kai Hübel Ann E. Woolfrey Mary E.D. Flowers Rainer Storb Brenda M. Sandmaier 《Haematologica》2014,99(10):1624-1631
The study is a randomized phase II trial investigating graft-versus-host disease prophylaxis after non-myeloablative (90 mg/m2 fludarabine and 2 Gy total body irradiation) human leukocyte antigen matched unrelated donor transplantation. Patients were randomized as follows: arm 1 – tacrolimus 180 days and mycophenolate mofetil 95 days (n=69); arm 2 – tacrolimus 150 days and mycophenolate mofetil 180 days (n=71); arm 3 – tacrolimus 150 days, mycophenolate mofetil 180 days and sirolimus 80 days (n=68). All patients had sustained engraftment. Grade II-IV acute graft-versus-host disease rates in the 3 arms were 64%, 48% and 47% at Day 150, respectively (arm 3 vs. arm 1 (hazard ratio 0.62; P=0.04). Owing to the decreased incidence of acute graft-versus-host disease, systemic steroid use was lower at Day 150 in arm 3 (32% vs. 55% in arm 1 and 49% in arm 2; overall P=0.009 by hazard ratio analysis). The Day 150 incidence of cytomegalovirus reactivation was lower in arm 3 (arm 1, 54%; arm 2, 47%; arm 3, 22%; overall P=0.002 by hazard ratio analysis). Non-relapse mortality was comparable in the three arms at two years (arm 1, 26%; arm 2, 23%; arm 3, 18%). Toxicity rates and other outcome measures were similar between the three arms. The addition of sirolimus to tacrolimus and mycophenolate mofetil is safe and associated with lower incidence of acute graft-versus-host disease and cytomegalovirus reactivation. (clinicaltrials.gov identifier: 00105001). 相似文献
996.
997.
Keith W. Kintigh Jeffrey H. Altschul Mary C. Beaudry Robert D. Drennan Ann P. Kinzig Timothy A. Kohler W. Fredrick Limp Herbert D. G. Maschner William K. Michener Timothy R. Pauketat Peter Peregrine Jeremy A. Sabloff Tony J. Wilkinson Henry T. Wright Melinda A. Zeder 《Proceedings of the National Academy of Sciences of the United States of America》2014,111(3):879-880
998.
Carri Cottengim Sharyn Parks Dale Rhoda Tom Andrew Kurt B. Nolte John Fudenberg Mary Ann Sens Jennifer Brustrom Betsy Payn Carrie K. Shapiro-Mendoza 《Forensic science, medicine, and pathology》2020,16(1):91-98
Understanding case identification practices, protocols, and training needs of medical examiners and coroners (MEC) may inform efforts to improve cause-of-death certification. We surveyed a U.S.-representative sample of MECs and described investigation practices and protocols used in certifying sudden unexpected infant deaths (SUID). We also identified MEC training and resource needs. Of the 377 respondents, use of the SUID Investigation Reporting Form or an equivalent was 89% for large, 87% for medium, and 52% for small jurisdictions. Routine completion of infant medical history, witness interviews, autopsy, photos or videos, and family social history for infant death investigations was ≥80%, but routine scene re-creation with a doll was 30% in small, 64% in medium, and 59% in large offices. Seventy percent of MECs reported infant death investigation training needs. Increased training and use of standardized practices may improve SUID cause-of-death certification, allowing us to better understand SUID. 相似文献
999.
Chi-Iou Lin Anne Merley Tracey E. Sciuto Dan Li Ann M. Dvorak Juan M. Melero-Martin Harold F. Dvorak Shou-Ching S. Jaminet 《Angiogenesis》2014,17(4):897-907
Transmembrane-4 L-six family member-1 (TM4SF1) is a small plasma membrane glycoprotein that regulates cell motility and proliferation. TM4SF1 is an attractive cancer target because of its high expression in both tumor cells and on the vascular endothelial cells lining tumor blood vessels. We generated mouse monoclonal antibodies against human TM4SF1 in order to evaluate their therapeutic potential; 13 of the antibodies we generated reacted with extracellular loop-2 (EL2), TM4SF1’s larger extracellular, lumen-facing domain. However, none of these antibodies reacted with mouse TM4SF1, likely because the EL2 of mouse TM4SF1 differs significantly from that of its human counterpart. Therefore, to test our antibodies in vivo, we employed an established model of engineered human vessels in which human endothelial colony-forming cells (ECFC) and human mesenchymal stem cells (MSC) are incorporated into Matrigel plugs that are implanted subcutaneously in immunodeficient nude mice. We modified the original protocol by (1) preculturing human ECFC on laminin, fibronectin, and collagen-coated plates, and (2) increasing the ECFC/MSC ratio. These modifications significantly increased the human vascular network in Matrigel implants. Two injections of one of our anti-TM4SF1 EL2 monoclonal antibodies, 8G4, effectively eliminated the human vascular component present in these plugs; they also abrogated human PC3 prostate cancer cells that were incorporated into the ECFC/MSC Matrigel mix. Together, these studies provide a mouse model for assessing tumor xenografts that are supplied by a human vascular network and demonstrate that anti-TM4SF1 antibodies such as 8G4 hold promise for cancer therapy. 相似文献
1000.